|
1）Yamagishi M, Watanabe T. Molecular hallmarks of adult T cell leukemia. Front Microbiol. 2012; 3: 334
|
|
|
|
|
2）Inoue J, Gohda J, Akiyama T, et al. NF-kappaB activation in development and progression of cancer. Cancer Sci. 2007; 98: 268-74
|
|
|
|
|
3）Lim KH, Yang Y, Staudt LM. Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies. Immunol Rev. 2012; 246: 359-78
|
|
|
|
|
|
4）Horie R, Watanabe T, Morishita Y, et al. Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin-Reed Sternberg cells. Oncogene. 2002; 21: 2493-503
|
|
|
|
|
|
5）Horie R, Watanabe M, Ishida T, et al. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-κB activation in anaplastic large cell lymphoma. Cancer Cell. 2004; 5: 353-64
|
|
|
|
|
|
6）Mori N, Fujii M, Ikeda S, et al. Constitutive activation of NF-κB in primary adult T-cell leukemia cells. Blood. 1999; 93: 2360-8
|
|
|
|
|
|
7）Hironaka N, Mochida K, Mori N, et al. Tax-independent constitutive IκB kinase activation in adult T-cell leukemia cells. Neoplasia. 2004; 6: 266-78
|
|
|
|
|
|
8）Watanabe M, Ohsugi T, Shoda M, et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood. 2005; 106: 2462-71
|
|
|
|
|
|
9）Saitoh Y, Yamamoto N, Dewan MZ, et al. Overexpressed NF-κB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells. Blood. 2008; 111: 5118-29
|
|
|
|
|
|
10）Yamagishi M, Nakano K, Miyake A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T-cell leukemia and other cancers. Cancer Cell. 2012; 21: 121-35
|
|
|
|
|
|
11）Dewan MZ, Terashima K, Taruishi M, et al. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappa B. J Virol. 2003; 77: 5286-94
|
|
|
|
|
|
12）Sanda T, Asamitsu K, Ogura H, et al. Induction of cell death in adult T-cell leukemia cells by a novel I kappa B kinase inhibitor. Leukemia. 2006; 20: 590-8
|
|
|
|
|
|
13）Ohsugi T, Yamaguchi K, Kumasaka T, et al. Rapid tumor death model for evaluation of new therapeutic agents for adult T-cell leukemia. Lab Invest. 2004; 84: 263-6
|
|
|
|
|
|
14）Ohsugi T, Horie R, Kumasaka T, et al. In vivo antitumor activity of the NF-κB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia. Carcinogenesis. 2005; 26: 1382-8
|
|
|
|
|